Inicio › Enfermedad de células falciformes › Pensilvania
Ensayos clínicos de Enfermedad de células falciformes en Pensilvania
20 estudios sobre Enfermedad de células falciformes buscan participantes en Pensilvania.
Ciudades en Pensilvania
Texto oficial del estudio (inglés)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Spoknwrdclinicaltrials, Easton
- Thomas Jefferson University Me, Philadelphia
ReclutandoFase 3
Edades de 12 a 100 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06439082A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- University of Pittsburgh Medical Center (UPMC), Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07187973A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Children's Hosptl Philadelphia, Philadelphia
- St Christopher Hosp for Child, Philadelphia
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT06612268A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- Childrens Hospital Of Philadelphia, Philadelphia
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 12 a 55 · Todos los sexos · Actualizado el 9 sept 2026 · NCT06546670A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0029, Philadelphia
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
- Local Institution - 0032, Pittsburgh
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Children's Hospital of Philadelphia, Philadelphia
- Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania, Philadelphia
- St. Christopher's Hospital for Children, Philadelphia
- y 1 más
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 17 ago 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Pittsburgh, Pittsburgh
- Hillman Cancer Center, Pittsburgh
ReclutandoFase 2
Edades de 12 en adelante · Todos los sexos · Actualizado el 14 ago 2026 · NCT06699849T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
ReclutandoFase 1/2
Edades de 5 a 40 · Todos los sexos · Actualizado el 13 ago 2026 · NCT03653338Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
- Children's Hospital of Philadelphia, Philadelphia
ReclutandoFase 1/2
Edades de 12 a 45 · Todos los sexos · Actualizado el 4 jun 2026 · NCT07252050Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Children's Hospital of Philadelphia (MRD-HCT), Philadelphia
ReclutandoEstudio observacional
Edades de 3 a 20 · Todos los sexos · Actualizado el 4 jun 2026 · NCT06941389Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
- Children's Hospital of Philadelphia, Philadelphia
ReclutandoFase 4
Edades de 18 a 50 · Mujeres · Actualizado el 28 may 2026 · NCT06665997A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
- Children's Hospital of Philadelphia, Philadelphia
Reclutando
Edades de 13 a 21 · Todos los sexos · Actualizado el 11 may 2026 · NCT06290401Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- Children's Hospital of Philadelphia, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
ReclutandoFase 2
Edades de 15 a 40 · Todos los sexos · Actualizado el 13 mar 2026 · NCT06260891Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease
- University of Pennsylvania, Philadelphia
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 feb 2026 · NCT07316478A Long-term Follow-up Study in Patients Who Received BEAM-101
- Children's Hospital of Philadelphia, Philadelphia
ReclutandoEstudio observacional
Edades de 14 a 37 · Todos los sexos · Actualizado el 28 ene 2026 · NCT07373639Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
ReclutandoEstudio observacional
2 Months – 60 Years · Todos los sexos · Actualizado el 13 ene 2026 · NCT04528355Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- UPMC University of Pittsburgh Classical Hematology Adult Clinic, Pittsburgh
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Reclutando
Edades de 16 a 30 · Todos los sexos · Actualizado el 7 ene 2026 · NCT06374238Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
ReclutandoFase 2
2 Months – 55 Years · Todos los sexos · Actualizado el 15 dic 2025 · NCT01962415Cutaneous Hydration Assessment in SCD
- UPMC Sickle Cell Clinic, Pittsburgh
Reclutando
Edades de 12 en adelante · Todos los sexos · Actualizado el 12 nov 2025 · NCT05210114Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- University of Pennsylvania, Philadelphia
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jun 2025 · NCT06385886De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.